Omalizumab Reduces Allergic Reactions to Multiple Foods in Youth
The monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume.
The monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume.
Two COPD therapies from Novartis -- Utibron Neohaler and Seebri Neohaler -- have been approved by the FDA for the long-term maintenance treatment of airflow obstruction in patients with COPD.